NDC product
Mucus Relief Cough and Congestion DM
NDC 17714-150 · Advance Pharmaceutical Inc.
Key facts
| Product NDC | 17714-150 |
|---|---|
| Proprietary name | Mucus Relief Cough and Congestion DM |
| Nonproprietary name | Guaifenesin and Dextromethorphan HBr |
| Substances | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN |
| Dosage form | TABLET |
| Route | ORAL |
| Labeler | Advance Pharmaceutical Inc. |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Application number | part341 |
| Pharmacologic classes | Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA] |
| Marketing start | Aug 1, 2017 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: